Marissa Walsh

PharmD, BCPS, BCIDP
Pharmacy

Specializing In:

Infectious diseases Antimicrobial Stewardship

Research Interests:

Antimicrobial stewardship, including process improvement, antimicrobial resistance and its impact on empiric and targeted antimicrobial selection Antimicrobial pharmacokinetics/pharmacodynamics Multi-drug resistant infections in immunocompromised hosts

About Marissa Walsh

Biography:

Marissa Walsh, PharmD, BCPS, BCIDP has been a Clinical Pharmacist Specialist at Roswell Park Comprehensive Cancer Center since 2015. She established clinical pharmacy services in the intensive care unit and founded the antimicrobial stewardship program with her infectious disease physician colleagues. She now focuses on clinical pharmacy services for the infectious disease consult service, co-manages the antimicrobial stewardship program, and serves as the Clinical Pharmacy Coordinator over acute care and surgical services

Positions

Roswell Park Comprehensive Cancer Center
  • Clinical Pharmacist Specialist, Infectious Diseases/Antimicrobial Stewardship
  • Clinical Coordinator, Acute Care Clinical Pharmacy Services
  • Pharmacy Services

Background

Education and Training:

  • 2003-2009 - Pharm.D. - University of Rhode Island, Kingston, RI

Residency:

  • 2010-2011 - PGY-2 (Infectious Diseases) - Maine Medical Center, Portland, ME
  • 2009-2010 - PGY-1 - Charleston Area Medical Center, Charleston, WV

Board Certification:

  • Board of Pharmacy Specialties - Board Certified Pharmacotherapy Specialist (BCPS)
  • Board of Pharmacy Specialties - Board Certified Infectious Diseases Pharmacist (BCIDP)

Professional Memberships:

  • Society of Infectious Diseases Pharmacists

Professional Experience:

  • Clinical Pharmacy Coordinator, Antimicrobial Stewardship, University of Miami Hospital, Miami, FL
  • Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship, Maine Medical Center, Portland, ME

Publications

Chen G, Herr M, Nowak J, Ho C, Almyroudis N, Attwood K, Bonnewell J, Walsh M, Segal B, Ross M, McCarthy P, Hahn T. Cytomegalovirus reactivation after CD19 CAR T cell therapy is clinically significant. Haematologica; https://doi.org/10.3324/haematol.2022.281719 [Early view].
 

Sfeir M, Walsh M, Rossana R, et al. Mycobacterium abscessus Complex Infections: A retrospective cohort study. Open Forum Infect Dis 2018; 5(2): ofy022.